C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2002
11/07/2002	US20020165129 Peptides and their use to ameliorate cell death
11/07/2002	US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/07/2002	CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	CA2445702A1 Control of compactability through crystallization
11/07/2002	CA2445290A1 A pharmaceutical tablet having a high api content
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254179A1 An in vivo screen using chemical inducers of dimerization
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254165A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254163A2 Targeting peptides
11/06/2002	EP1254159A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/06/2002	EP1254154A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254150A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254141A1 Camptothecin -beta-alanine esters with topoisomerase i inibhition
11/06/2002	EP1254108A1 Gamma-secretase inhibitors
11/06/2002	EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002	EP0800528B1 Peptide and peptide analog protease inhibitors
11/06/2002	CN1378559A Process for production of aspartyldipeptide ester derivatives, novel intermediates therefor and process for production of intermediates
11/06/2002	CN1378558A Processes for producing and purifying aspartame derivatives and process for producing intemediates
11/06/2002	CN1378557A Sweetener compositions with high degree of sweeteness having improved sweeteness, corrigents and utilization thereof
11/06/2002	CN1378556A Process for producing aspartame derivative, crystals thereof, novel production intermediates therefor and process for producing intermediate
11/06/2002	CN1378555A Basic salts of N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylanamine 1-methyl ester
11/06/2002	CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/05/2002	US6476263 Compounds for inhibiting β-amyloid peptide release and/or its synthesis
11/05/2002	US6475989 Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders
11/05/2002	US6475988 Methods to increase white blood cell survival after chemotherapy
11/05/2002	CA2109322C Bombesin analogs
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/05/2002	CA2037779C Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
10/2002
10/31/2002	WO2002085927A1 Novel anti-inflammatory peptides
10/31/2002	WO2002085847A2 Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof
10/31/2002	WO2002085840A1 Process for producing n-formylamino acid and utilization thereof
10/31/2002	WO2002042412A3 Protease inhibitors and their pharmaceutical uses
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020161189 Used in the antagonism and agonism of delta and mu opioid receptors
10/31/2002	US20020161038 Inosine 5'-monophosphate dehydrogenase (IMPDH); prodrug having functional group -CO-N(-R)-COO-, a carrier, and an immunosuppressant, anticancer agent, antiviral agent, or anti-vascular hyperproliferation agent
10/31/2002	US20020160962 Non-structural protein 3 (NS3), part of a hepatitis C virus protease necessary for polypeptide processing and viral replication; alpha-ketoamide compounds of given formula
10/31/2002	US20020160383 Use of nucleic acid analogues in diagnostics and analytical procedures
10/31/2002	CA2444579A1 Process for producing n-formylamino acid and utilization thereof
10/30/2002	EP1252826A1 Non-caking aspartame fine grade
10/30/2002	EP1252337A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252192A2 Enhancing the circulating half-life of antibody-based fusion proteins
10/30/2002	EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252179A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
10/30/2002	EP1252178A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
10/30/2002	EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1251865A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
10/30/2002	CN1377276A Protein polymerization inhibitors and methods of use
10/30/2002	CN1377275A Peptides that block viral infectivity and methods of use thereof
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1376677A [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
10/29/2002	US6472537 Polyamides for binding in the minor groove of double stranded DNA
10/29/2002	US6472522 Purification of oligomers using dual-end selection
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002	US6472398 Spiropiperidine derivatives as melanocortin receptor agonists
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083729A2 Polypeptides derived from amyloid precursor peptide (app) and their uses
10/24/2002	WO2002083716A2 Type b botulism toxin inhibitors
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002038540A3 Activity-dependent cysteine protease profiling reagent
10/24/2002	US20020156273 Streptogramin derivatives, their preparation and compositions which contain them
10/24/2002	US20020156237 Novel amide-based cationic lipids
10/24/2002	US20020156094 Sulfonamide interleukin-1beta converting enzyme inhibitors
10/24/2002	US20020155565 FAP-activated anti-tumor compounds
10/24/2002	US20020155496 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device
10/24/2002	US20020155455 Marker compound for use as visualization tool in genetic engineering
10/24/2002	CA2444530A1 Polypeptides, derivatives and uses thereof
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2443811A1 Type b botulism toxin inhibitors
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/23/2002	EP0826000B1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
10/23/2002	EP0723552B1 Oligopeptides derived from c-reactive protein fragments
10/23/2002	CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/22/2002	US6469207 Hiv protease inhibitors; administering to treat aids (acquired immune deficiency syndrome)
10/22/2002	US6469137 Myelopeptides and their therapeutic use
10/22/2002	US6469036 Peptidyl heterocyclic ketones useful as tryptase inhibitors

1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 307